This federal contract award, valued at $3,425.95, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on November 29, 2024. The contract is a delivery order for the pharmaceutical product Esbriet 801 mg tablet, with an ultimate completion date of December 20, 2024. The contract type is firm fixed price. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 3/2/25, 12:44 AM